FBN Securities initiated coverage on Cadence Design Systems Inc. (NASDAQ:CDNS) with an outperform rating and a $375 price target, citing its strong position in electronic design automation, recurring revenue model, and impressive gross profit margin. The firm highlighted durable secular tailwinds such as increasing design complexity, the impact of AI on demand acceleration, and a broadening foundry ecosystem. Despite some concerns like unquantified AI monetization and integration effects, the stock's current valuation is below its seven-year averages, leading to a "strong buy" consensus from Wall Street analysts.

Piper Sandler has initiated coverage of Fidelity National Information Services (FIS) with a "neutral" rating and a $42 price target, indicating a potential 9% upside. This comes amidst mixed analyst sentiment, with FIS holding a "Hold" consensus rating, and having recently surpassed quarterly earnings expectations. The company reported $1.48 EPS on revenues of $3.38 billion, a 29.1% increase year-over-year.

Costco's recent stock pullback presents a rare buying opportunity, with 24/7 Wall St. setting a 12-month price target of $1,011.88 (12.13% upside) and a five-year target of $1,204.89. The company delivered a strong Q3 fiscal 2026 report with double-digit revenue growth and high membership renewal rates, contrasting with slower growth seen in competitors like Walmart. Analysts maintain a bullish outlook on Costco, driven by increasing executive memberships and digital sales.

Piper Sandler has initiated coverage on Jack Henry & Associates Inc. (NASDAQ:JKHY) with a Neutral rating and a $171.00 price target, viewing the company as a high-quality infrastructure business with durable cash generation. Despite its strong fundamentals, including 22 consecutive years of dividend growth, the firm considers its current valuation full, seeing the risk-reward as balanced. This contrasts with InvestingPro’s Fair Value analysis, which suggests the stock might be undervalued.

The article reviews the Q2 earnings season for industrial packaging stocks, highlighting Avery Dennison (NYSE:AVY) as a top performer with strong revenue growth. It also details the performance of other key players like Crown Holdings, Packaging Corporation of America, International Paper, and Silgan Holdings, noting that while the sector reported strong revenues, share prices have generally declined since earnings reports. The piece touches on recent market uncertainties, including AI and geopolitical events, but emphasizes the importance of strong fundamentals.

RedChip Companies will air interviews with Anixa Biosciences Inc. (NASDAQ:ANIX) and Nexalin Technology Inc. (NASDAQ:NXL) on their "Small Stocks, Big Money™" show. The interviews will be broadcast on Bloomberg TV on September 12 and on CNBC on September 13. Anixa Biosciences will discuss its breast cancer vaccine, while Nexalin Technology will highlight its drug-free neurostimulation platform for mental health and neurological disorders.

Genuine Parts Co., parent company of NAPA Auto Parts, has released more details regarding its plan to split its automotive and industrial businesses into two independent, publicly traded companies by Q1 2027. The automotive business will operate as Genuine Parts Co. (GPC) and the industrial business as Motion. The company has also announced key leadership appointments for both entities, with Court Carruthers becoming CEO-elect of GPC and Will Stengel serving as chairman and CEO of Motion.

Anixa Biosciences CEO Amit Kumar recently acquired 5,000 shares of the company's stock for $13,800, increasing his direct ownership to 662,000 shares. This purchase follows several other insider acquisitions in recent months. The company's stock opened at $2.75, down 2.8%, with a market capitalization of $93.6 million, and analysts currently hold a "Hold" rating with a $10 average price target.

Anixa Biosciences CEO Amit Kumar recently purchased 5,000 shares of the company's common stock for $13,799, at a price of $2.76 per share. This transaction increases his direct holdings to 662,000 shares, occurring while the stock is near its 52-week low. Despite the stock appearing overvalued by some analyses, the company maintains a strong balance sheet and is advancing its clinical trials for cancer therapies.

Waters Corporation announced that its President and CEO, Udit Batra, Ph.D., will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference on September 23, 2026. The event will be webcast live on the company's Investor Relations website, with a replay available for 90 days. Waters Corporation is a global leader in life sciences and diagnostics, focused on analytical technologies and informatics.